Wendy L St Peter

Summary

Affiliation: Chronic Disease Research Group
Country: USA

Publications

  1. doi request reprint A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 51:445-54. 2008
  2. doi request reprint Improving medication safety in chronic kidney disease patients on dialysis through medication reconciliation
    Wendy L St Peter
    University of Minnesota, Minneapolis, USA
    Adv Chronic Kidney Dis 17:413-9. 2010
  3. pmc Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months
    Wendy L St Peter
    University of Minnesota College of Pharmacy, Minneapolis, MN, USA
    BMC Nephrol 14:249. 2013
  4. ncbi request reprint Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results
    Wendy L St Peter
    The College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
    Hemodial Int 12:480-91. 2008
  5. pmc Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 406, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 4:354-60. 2009
  6. doi request reprint Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Pharmacotherapy 29:154-64. 2009
  7. pmc Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, University of Minnesota, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 4:1954-61. 2009
  8. doi request reprint Potential impact of Medicare Part D in the end-stage renal disease population
    Wendy L St Peter
    College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
    Adv Chronic Kidney Dis 15:140-6. 2008
  9. ncbi request reprint Trends in intravenous iron use among dialysis patients in the United States (1994-2002)
    Wendy L St Peter
    US Renal Data System, Minneapolis, MN 55404, USA
    Am J Kidney Dis 46:650-60. 2005
  10. ncbi request reprint Anemia treatment in the pre-ESRD period and associated mortality in elderly patients
    Jay L Xue
    Nephrology Analytical Services, Minneapolis, MN, USA
    Am J Kidney Dis 40:1153-61. 2002

Detail Information

Publications31

  1. doi request reprint A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 51:445-54. 2008
    ..Many patients were lost to follow-up, precluding intent-to-treat analysis by using prospective data collection...
  2. doi request reprint Improving medication safety in chronic kidney disease patients on dialysis through medication reconciliation
    Wendy L St Peter
    University of Minnesota, Minneapolis, USA
    Adv Chronic Kidney Dis 17:413-9. 2010
    ..Adequately powered trials are necessary to demonstrate that medication reconciliation can improve dialysis patient outcomes and cost...
  3. pmc Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months
    Wendy L St Peter
    University of Minnesota College of Pharmacy, Minneapolis, MN, USA
    BMC Nephrol 14:249. 2013
    ....
  4. ncbi request reprint Linking Centers for Medicare & Medicaid Services data with prospective DCOR trial data: methods and data comparison results
    Wendy L St Peter
    The College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
    Hemodial Int 12:480-91. 2008
    ..Linking patients to the data-rich CMS ESRD database allowed assessment of additional important secondary end points at a relatively low cost compared with prospective data collection...
  5. pmc Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S 406, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 4:354-60. 2009
    ....
  6. doi request reprint Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Pharmacotherapy 29:154-64. 2009
    ....
  7. pmc Economic evaluation of sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using centers for Medicare & Medicaid services data
    Wendy L St Peter
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, University of Minnesota, Minneapolis, MN 55404, USA
    Clin J Am Soc Nephrol 4:1954-61. 2009
    ....
  8. doi request reprint Potential impact of Medicare Part D in the end-stage renal disease population
    Wendy L St Peter
    College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
    Adv Chronic Kidney Dis 15:140-6. 2008
    ..The complexities of Medicare Part D make problems inevitable; ESRD patients may be more vulnerable to these problems than the general Medicare population, but further data are needed...
  9. ncbi request reprint Trends in intravenous iron use among dialysis patients in the United States (1994-2002)
    Wendy L St Peter
    US Renal Data System, Minneapolis, MN 55404, USA
    Am J Kidney Dis 46:650-60. 2005
    ..We report trends in IV iron use in both incident (1994 to 2001) and prevalent (1994 to 2002) Medicare US dialysis patients...
  10. ncbi request reprint Anemia treatment in the pre-ESRD period and associated mortality in elderly patients
    Jay L Xue
    Nephrology Analytical Services, Minneapolis, MN, USA
    Am J Kidney Dis 40:1153-61. 2002
    ..Anemia is a common complication of advancing chronic kidney disease, yet little is known about the consistency of anemia treatment before end-stage renal disease (ESRD) and mortality on dialysis therapy...
  11. ncbi request reprint Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients
    Tricia L Roberts
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 66:2429-36. 2004
    ..Recent data suggest that VA type contributes to recombinant human erythropoietin (rHuEPO) resistance. We examined catheter insertions, VA infections, and anemia management in Medicare, rHuEPO-treated, chronic hemodialysis patients...
  12. ncbi request reprint Chronic kidney disease: the distribution of health care dollars
    Wendy L St Peter
    Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA
    Kidney Int 66:313-21. 2004
    ..The cost of care for end-stage renal disease (ESRD) is known to be high. The factors responsible for higher ESRD cost develop during chronic kidney disease (CKD), where the data on distribution of cost are limited...
  13. pmc Medication reconciliation and therapy management in dialysis-dependent patients: need for a systematic approach
    Amy Barton Pai
    Department of Pharmacy Practice, ANephRx Albany Nephrology Pharmacy Group, Albany College of Pharmacy and Health Sciences, Albany, New York, Reach Medication Therapy Management, Dialysis Clinic, Inc, Albany, New York, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, US Renal Data System and Chronic Disease Research Group, Minneapolis, Minnesota, Policy and Government Affairs, American Society of Nephrology, Washington, DC, Division of Nephrology, Boston Children s Hospital, Boston, Massachusetts, Division of Nephrology, Harborview Medical Center and Kidney Research Institute, University of Washington, Seattle, Washington
    Clin J Am Soc Nephrol 8:1988-99. 2013
    ..Herein, this work provides a review of available evidence and recommendations for optimal delivery of medication management services to ESRD patients in a dialysis facility-centered model. ..
  14. doi request reprint Clinical outcomes associated with receipt of integrated pharmacy services by hemodialysis patients: a quality improvement report
    Eric D Weinhandl
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN 55404, USA
    Am J Kidney Dis 62:557-67. 2013
    ..In 2005, a large US dialysis organization created an integrated pharmacy program for its patients. We aimed to compare the outcomes of hemodialysis patients enrolled in this program and matched control patients...
  15. ncbi request reprint United States Renal Data System assessment of the impact of the National Kidney Foundation-Dialysis Outcomes Quality Initiative guidelines
    Allan J Collins
    US Renal Data System and US Renal Data System Information System, Minneapolis, MN 55404, USA
    Am J Kidney Dis 39:784-95. 2002
    ..Although it appears that clinical practice guidelines have improved the clinical care of dialysis patients, considerable regional variations in care across the country should be given significant attention...
  16. ncbi request reprint Role of collaborative care models including pharmacists in improving blood pressure management in chronic kidney disease patients
    Wendy L St Peter
    College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55404, USA
    Curr Opin Nephrol Hypertens 20:498-503. 2011
    ..This review will focus on the evidence which demonstrates the important role of the pharmacist in collaboration with physicians within primary care practices to improve blood pressure management in CKD patients...
  17. doi request reprint Trends in hip fracture rates in US hemodialysis patients, 1993-2010
    Thomas J Arneson
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, MN Electronic address
    Am J Kidney Dis 62:747-54. 2013
    ..Changes in mineral and bone disorder treatment patterns and demographic changes in the dialysis population may have influenced hip fracture rates in US dialysis patients in 1993-2010...
  18. doi request reprint Issues regarding 'immortal time' in the analysis of the treatment effects in observational studies
    Jiannong Liu
    United States Renal Data System, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
    Kidney Int 81:341-50. 2012
    ..Results from the DaVita data were consistent with the simulation. Careful consideration of methodology is needed in observational analyses with time-dependent treatment...
  19. ncbi request reprint Introduction: chronic kidney disease: a burgeoning health epidemic
    Wendy L St Peter
    College of Pharmacy at the University of Minnesota, Minneapolis, MN 55404, USA
    J Manag Care Pharm 13:S2-5. 2007
    ..At this point in the disease process, few opportunities exist to prevent adverse outcomes...
  20. doi request reprint Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007
    Suying Li
    Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Minneapolis, MN 55404, USA
    Am J Kidney Dis 57:602-11. 2011
    ..Parathyroidectomy rates in hemodialysis patients increased from 1992 to 2002, when medication choices to manage secondary hyperparathyroidism expanded...
  21. ncbi request reprint Prevalence of anemia in erythropoietin-treated pediatric as compared to adult chronic dialysis patients
    Blanche M Chavers
    Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota 55455, USA
    Kidney Int 65:266-73. 2004
    ..Recent guidelines recommend a target hemoglobin range of 11 to 12 g/dL in pediatric and adult dialysis patients. We compared anemia prevalence in United States Medicare pediatric and adult dialysis patients...
  22. ncbi request reprint Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes
    Wendy L St Peter
    College of Pharmacy, University of Minnesota, Division of Nephrology, Hennepin County Medical Center, Minneapolis, MN 55404, USA
    Am J Kidney Dis 41:903-24. 2003
    ....
  23. pmc New models of chronic kidney disease care including pharmacists: improving medication reconciliation and medication management
    Wendy L St Peter
    aChronic Disease Research Group, Minneapolis Medical Research Foundation bCollege of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA cManitoba Renal Program dWinnipeg Regional Health Authority Pharmacy Program, Winnipeg, Manitoba, Canada eDepartment of Medicine, Duke University Medical Center, Durham, North Carolina, USA
    Curr Opin Nephrol Hypertens 22:656-62. 2013
    ..This review discusses reasons for gaps in medication-related care for CKD patients, pharmacy services to reduce these gaps and successful models that incorporate pharmacist care...
  24. ncbi request reprint Medicare Part D: challenges for dialysis patients. Part 1
    Stephanie Smith
    University of Minnesota, College of Pharmacy, USA
    Nephrol News Issues 25:38-40, 42, 44-5. 2011
    ..The anticipated shift of self-administered bone and mineral disorder medications from Part D into the dialysis bundle in 2014 has the potential to affect dialysis patients' access to these medications...
  25. doi request reprint Association between copayment and adherence to statin treatment initiated after coronary heart disease hospitalization: a longitudinal, retrospective, cohort study
    Xin Ye
    College of Pharmacy, University of Minnesota, Minneapolis, Minnesota, USA
    Clin Ther 29:2748-57. 2007
    ..Despite substantial evidence supporting the effectiveness of statin treatment, when administered regularly for the secondary prevention of coronary heart disease (CHD), many patients are not adherent...
  26. ncbi request reprint Chronic kidney disease and medicare
    Wendy L St Peter
    College of Pharmacy at the University of Minnesota, Minneapolis, MN 55404, USA
    J Manag Care Pharm 13:S13-8. 2007
    ..The ESRD population faces significant hurdles when using the new Part D benefit. To understand those challenges, a basic understanding of Part D is needed...
  27. pmc Comparative effectiveness of calcium acetate and sevelamer on clinical outcomes in elderly hemodialysis patients enrolled in medicare part d
    Akeem A Yusuf
    US Renal Data System, Minneapolis Medical Research Foundation, Minneapolis, MN University of Minnesota, College of Pharmacy, Minneapolis, MN
    Am J Kidney Dis 64:95-103. 2014
    ..Phosphate binders are an important therapeutic option for managing hyperphosphatemia in hemodialysis patients. Whether sevelamer confers a survival advantage over calcium acetate is unclear...
  28. doi request reprint To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease
    Wendy L St Peter
    College of Pharmacy, University of Minnesota, Minneapolis, MN, USA
    Pharmacotherapy 33:496-514. 2013
    ..Finally, we suggest a clinical approach for using RAS agents in patients with DKD...
  29. ncbi request reprint Hospitalization during advancing chronic kidney disease
    T Christian H Mix
    Tufts New England Medical Center, Boston, MA, USA
    Am J Kidney Dis 42:972-81. 2003
    ..However, the influence of declining kidney function on hospitalization as ESRD approaches is not well understood...
  30. ncbi request reprint Medication-related problems in ambulatory hemodialysis patients: a pooled analysis
    Harold J Manley
    Albany College of Pharmacy, Albany, NY 12208, USA
    Am J Kidney Dis 46:669-80. 2005
    ..We conducted a pooled analysis to gain additional insight into the frequency, type, and severity of medication-related problems and extrapolated the data to the entire US HD population...
  31. ncbi request reprint Initiation of statins after hospitalization for coronary heart disease
    Xin Ye
    i3 Innovus, Eden Prairie, MN 55344, USA
    J Manag Care Pharm 13:385-96. 2007
    ..It has been well recognized that patients with prior CHD are at very high risk for recurrent CHD. Statins have been recommended as an effective treatment in the secondary prevention of CHD...